CL2016001553A1 - Medios para cultivo celular - Google Patents
Medios para cultivo celularInfo
- Publication number
- CL2016001553A1 CL2016001553A1 CL2016001553A CL2016001553A CL2016001553A1 CL 2016001553 A1 CL2016001553 A1 CL 2016001553A1 CL 2016001553 A CL2016001553 A CL 2016001553A CL 2016001553 A CL2016001553 A CL 2016001553A CL 2016001553 A1 CL2016001553 A1 CL 2016001553A1
- Authority
- CL
- Chile
- Prior art keywords
- media
- cell culture
- phosphatidylcholine
- cholesterol
- concentration
- Prior art date
Links
- 238000004113 cell culture Methods 0.000 title 1
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 abstract 4
- 235000012000 cholesterol Nutrition 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 abstract 2
- 238000005138 cryopreservation Methods 0.000 abstract 1
- 235000014113 dietary fatty acids Nutrition 0.000 abstract 1
- 229930195729 fatty acid Natural products 0.000 abstract 1
- 239000000194 fatty acid Substances 0.000 abstract 1
- 150000004665 fatty acids Chemical class 0.000 abstract 1
- 239000002502 liposome Substances 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/10—Preservation of living parts
- A01N1/12—Chemical aspects of preservation
- A01N1/122—Preservation or perfusion media
- A01N1/126—Physiologically active agents, e.g. antioxidants or nutrients
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/35—Polyols, e.g. glycerin, inositol
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/36—Lipids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/46—Amines, e.g. putrescine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/50—Soluble polymers, e.g. polyethyleneglycol [PEG]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/60—Buffer, e.g. pH regulation, osmotic pressure
- C12N2500/62—DMSO
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/30—Synthetic polymers
- C12N2533/32—Polylysine, polyornithine
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Environmental Sciences (AREA)
- Dentistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Biophysics (AREA)
- Physiology (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361918833P | 2013-12-20 | 2013-12-20 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2016001553A1 true CL2016001553A1 (es) | 2017-03-17 |
Family
ID=53399356
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2016001553A CL2016001553A1 (es) | 2013-12-20 | 2016-06-16 | Medios para cultivo celular |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9637721B2 (enExample) |
| EP (1) | EP3083978A4 (enExample) |
| JP (1) | JP2017500893A (enExample) |
| KR (1) | KR20160125352A (enExample) |
| CN (1) | CN106062205A (enExample) |
| AR (1) | AR098875A1 (enExample) |
| AU (1) | AU2014364368A1 (enExample) |
| BR (1) | BR112016014488A2 (enExample) |
| CA (1) | CA2934487A1 (enExample) |
| CL (1) | CL2016001553A1 (enExample) |
| EA (1) | EA201691297A1 (enExample) |
| IL (1) | IL246262A0 (enExample) |
| MX (1) | MX2016008251A (enExample) |
| SG (1) | SG11201604994UA (enExample) |
| TW (1) | TW201527534A (enExample) |
| WO (1) | WO2015095651A1 (enExample) |
Families Citing this family (49)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10918102B2 (en) | 2014-03-13 | 2021-02-16 | The General Hospital Corporation | Devices and methods to improve and assess viability of human livers |
| MX2017008737A (es) | 2014-12-30 | 2018-01-25 | Cell Cure Neurosciences Ltd | Poblaciones de celulas rpe y metodos para generar las mismas. |
| KR102783900B1 (ko) | 2015-10-15 | 2025-03-19 | 웨이크 포리스트 유니버시티 헬스 사이언시즈 | 인 비트로 간 구조체의 제조방법 및 그의 용도 |
| EP3362554B1 (en) | 2015-10-16 | 2025-09-03 | Wake Forest University Health Sciences | Multi-layer airway organoids and methods of making and using the same |
| US20180369336A1 (en) * | 2015-12-03 | 2018-12-27 | Boston Medical Center Corporation | B cell-based cancer immunotherapy |
| CN105567628B (zh) * | 2016-01-30 | 2019-07-12 | 令世鑫 | 一种全悬浮培养mdck细胞的低血清培养基 |
| CN105695407B (zh) * | 2016-03-15 | 2019-04-16 | 佰通生物技术(苏州)有限公司 | 一种对干细胞具有活化作用的微量元素组合物及其应用 |
| CN108779436A (zh) * | 2016-03-18 | 2018-11-09 | 中国科学院生物物理研究所 | 一种细胞培养基和培养基补充物 |
| TW202140776A (zh) | 2016-04-26 | 2021-11-01 | 美商美國泰福生技股份有限公司 | 細胞培養基 |
| CN106119186B (zh) * | 2016-06-24 | 2019-10-08 | 肇庆大华农生物药品有限公司 | 一种用于全悬浮培养mdck细胞的无血清培养基及其制备方法 |
| CN106497872B (zh) * | 2016-12-01 | 2019-10-11 | 北京欣博睿丰医疗科技发展有限公司 | 骨骼肌干细胞无血清培养基及其制备方法和应用 |
| US12087399B2 (en) * | 2017-02-01 | 2024-09-10 | Sapphiros Ai Bio Llc | Systems and methods for customizing cell culture media for optimized cell proliferation based on genetic traits of cells |
| JP7181534B2 (ja) * | 2017-03-28 | 2022-12-01 | 味の素株式会社 | 未分化維持培地添加剤 |
| CN107177542A (zh) * | 2017-05-25 | 2017-09-19 | 句容亿格纳米材料厂 | 一种促进培养基中谷氨酰胺溶解的优化方法 |
| US12234484B2 (en) * | 2017-05-31 | 2025-02-25 | Promocell Gmbh | Culture medium for pluripotent stem cells |
| US12058996B2 (en) * | 2017-06-14 | 2024-08-13 | The General Hospital Corporation | High subzero cryopreservation |
| CN107488625B (zh) * | 2017-08-31 | 2018-12-21 | 广州蕊特生物科技有限公司 | 一种胎牛血清替代物及其制备方法和应用 |
| CN109395095B (zh) * | 2017-09-18 | 2021-09-24 | 武汉原生原代生物医药科技有限公司 | 体内用生物膜及其制备方法和用途 |
| JP7379348B2 (ja) * | 2017-10-11 | 2023-11-14 | バスト バイオテクノロジー | 線維症の治療のための組成物および方法 |
| JP7117374B2 (ja) * | 2017-10-13 | 2022-08-12 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 灌流培地 |
| WO2019081609A1 (en) * | 2017-10-24 | 2019-05-02 | Fundación Instituto De Investigación Sanitaria De Santiago De Compostela (Fidis) | NANOSYSTEMS FOR CELL PROLIFERATION |
| KR102569522B1 (ko) * | 2017-11-24 | 2023-08-24 | 주식회사 차바이오랩 | 세포 동결 보존용 조성물 및 이를 이용한 세포 동결 보존 방법 |
| SG11202005795TA (en) * | 2017-12-29 | 2020-07-29 | Cell Cure Neurosciences Ltd | Retinal pigment epithelium cell compositions |
| US12167729B2 (en) | 2018-05-30 | 2024-12-17 | The General Hospital Corporation | Cryopreservation of tissues and organs |
| CN108815516B (zh) * | 2018-06-29 | 2019-03-15 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv灭活疫苗的方法 |
| CN108853489B (zh) * | 2018-06-29 | 2019-07-02 | 陕西诺威利华生物科技有限公司 | 一种利用无血清培养基生产pedv弱毒疫苗的方法 |
| CN109234223B (zh) * | 2018-11-21 | 2021-01-19 | 南京基蛋生物医药有限公司 | 低蛋白无血清细胞培养基 |
| KR102271949B1 (ko) * | 2019-04-15 | 2021-07-02 | 순천향대학교 산학협력단 | 포스파티딜콜린을 함유하는 선충 배양용 조성물 및 이를 이용한 선충의 배양방법 |
| WO2020218584A1 (ja) * | 2019-04-26 | 2020-10-29 | 味の素株式会社 | 細胞培養用組成物 |
| KR102132457B1 (ko) * | 2019-05-10 | 2020-07-09 | 주식회사 바이오솔루션 | 세포외 소포를 고농도로 배양하기 위한 세포 배양배지 및 상기 세포 배양배지를 이용한 세포외 소포 고 함유 조건화 배양액의 제조방법 |
| CN109943526B (zh) * | 2019-05-23 | 2019-09-13 | 广州赛莱拉干细胞科技股份有限公司 | 一种促间充质干细胞增殖的无血清多肽组合物 |
| WO2021078935A1 (en) * | 2019-10-25 | 2021-04-29 | Fundació Centre De Regulació Genòmica | Culture media for mycoplasma |
| US12297451B1 (en) | 2019-10-25 | 2025-05-13 | Regeneron Pharmaceuticals, Inc. | Cell culture medium |
| WO2021108806A1 (en) * | 2019-11-29 | 2021-06-03 | Rutgers, The State University Of New Jersey | Compositions, kits and methods for storage of blood products and methods of use thereof |
| AU2021211230A1 (en) * | 2020-01-21 | 2022-09-01 | Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. | Utilization of FGF activators in culture media |
| CN111849860B (zh) * | 2020-06-01 | 2021-12-21 | 浙江大学 | 一种利用铁元素调控肠道干细胞分化的方法及应用 |
| WO2021248141A1 (en) * | 2020-06-05 | 2021-12-09 | Upside Foods, Inc. | Nutrient media for the production of slaughter-free meat |
| CN111534478A (zh) * | 2020-06-24 | 2020-08-14 | 肇庆大华农生物药品有限公司 | 用于培养mdck细胞系的培养基及其制备方法 |
| US20220142150A1 (en) * | 2020-11-10 | 2022-05-12 | Axogen Corporation | Packaging system for a medical product |
| CN112514892B (zh) * | 2020-12-25 | 2022-06-14 | 广州赛莱拉干细胞科技股份有限公司 | 一种外泌体冻存保护液及其制备方法 |
| CN112501113B (zh) * | 2021-02-03 | 2021-04-27 | 上海奥浦迈生物科技股份有限公司 | 一种hek293细胞组合梯度培养基及其用途 |
| CN113061584A (zh) * | 2021-05-14 | 2021-07-02 | 赵峻岭 | 一种能促进腺病毒生长的培养基添加物 |
| EP4381045A4 (en) * | 2021-08-02 | 2025-06-04 | Montana State University | Chemically defined serum replacements for cell culture |
| US11878036B2 (en) | 2022-05-25 | 2024-01-23 | Neuvian LLC | Vaginal care compositions and methods of improving vaginal health |
| EP4563695A1 (en) * | 2022-07-28 | 2025-06-04 | Sanyo-Onoda City Public University Corporation | Composition for cryopreservation, cryopreservation method, and frozen cell or biological tissue |
| KR20240177180A (ko) * | 2023-06-19 | 2024-12-27 | (주)엑셀세라퓨틱스 | T 세포 배양용 배지 조성물 |
| WO2025098952A1 (en) | 2023-11-07 | 2025-05-15 | Evonik Operations Gmbh | Nutrient preloading of cells |
| WO2025199245A1 (en) * | 2024-03-19 | 2025-09-25 | Immunis, Inc. | Method of making and using secretome composition |
| US12421441B1 (en) | 2025-05-19 | 2025-09-23 | King Fahd University Of Petroleum And Minerals | Method for microbially enhanced oil recovery |
Family Cites Families (33)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4721676A (en) * | 1982-12-14 | 1988-01-26 | Genencor, Inc. | Novel thermophile isolate having thermostable hydrolytic activity |
| US4560655A (en) | 1982-12-16 | 1985-12-24 | Immunex Corporation | Serum-free cell culture medium and process for making same |
| DE3827578A1 (de) | 1988-08-13 | 1990-02-15 | Siepmann Friedrich W | Verfahren und vorrichtung zur bestimmung oxidierbarer wasserinhaltsstoffe einer waessrigen probenfluessigkeit |
| US6048728A (en) | 1988-09-23 | 2000-04-11 | Chiron Corporation | Cell culture medium for enhanced cell growth, culture longevity, and product expression |
| US5834312A (en) | 1990-01-29 | 1998-11-10 | Hy-Gene, Inc. | Process and media for the growth of human epithelia |
| US5952198A (en) * | 1995-05-04 | 1999-09-14 | Bayer Corporation | Production of recombinant Factor VIII in the presence of liposome-like substances of mixed composition |
| AU6698196A (en) | 1995-08-15 | 1997-03-12 | Universite Libre De Bruxelles | Liposomes preparation method and plant |
| JP4421681B2 (ja) * | 1995-10-19 | 2010-02-24 | バイオ‐オリジン エルエルシー | 生殖細胞および胚の生存および機能を改善する方法および組成物 |
| EP2243827B2 (en) | 1996-08-30 | 2017-11-22 | Life Technologies Corporation | Serum-free mammalian cell culture medium, and uses thereof |
| AU4751697A (en) | 1996-10-10 | 1998-05-05 | Douglas Danner | Animal cell culture media comprising plant-derived nutrients |
| US6833271B2 (en) | 1996-12-04 | 2004-12-21 | Medi-Cult A/S | Serum-free cell culture media |
| US5985538A (en) | 1997-08-01 | 1999-11-16 | Saint Barnabas Medical Center | Cryopreservation and cell culture medium comprising less than 50 mM sodium ions and greater than 100 mM choline salt |
| GB9817805D0 (en) | 1998-08-14 | 1998-10-14 | Danisco | Use of a composition |
| DK1226233T3 (da) | 1999-08-05 | 2011-10-03 | Abt Holding Co | Multipotente voksne stamceller og fremgangsmåder til isolering heraf |
| US7112576B1 (en) | 1999-12-10 | 2006-09-26 | Regents Of The University Of Minnesota | Compositions and methods for cryopreservation of peripheral blood lymphocytes |
| US7455983B2 (en) | 2000-01-11 | 2008-11-25 | Geron Corporation | Medium for growing human embryonic stem cells |
| WO2003064598A2 (en) | 2002-01-25 | 2003-08-07 | Genzyme Corporation | Serum-free media for chondrocytes and methods of use thereof |
| EP1475434A1 (en) * | 2003-05-09 | 2004-11-10 | Oncoscience AG | Method for storing tumor cells |
| WO2005072523A2 (en) | 2004-02-02 | 2005-08-11 | I.M.T. Interface Multigrad Technology Ltd. | Biological material and methods and solutions for preservation thereof |
| US8252591B2 (en) | 2004-05-07 | 2012-08-28 | Whitehead Institute For Biomedical Research | Hormone responsive tissue culture system and uses thereof |
| US20050287666A1 (en) | 2004-06-29 | 2005-12-29 | Invitrogen Corporation | Cell culture medium comprising transition metals or trace elements |
| AU2005271723B2 (en) | 2004-07-13 | 2010-12-16 | Asterias Biotherapeutics, Inc. | Medium for growing human embryonic stem cells |
| US7767453B2 (en) | 2004-10-20 | 2010-08-03 | Whitehead Institute For Biomedical Research | Cultured hematopoietic stem cells and method for expansion and analysis thereof |
| WO2006108455A1 (en) | 2004-11-02 | 2006-10-19 | Ares Trading S.A. | Serum-free cell culture medium for mammalian cells |
| CA2595638A1 (en) * | 2005-01-28 | 2006-08-03 | Canadian Blood Services | A method of cryopreserving cells and tissues by liposomal delivery of sugars to enhance post-thaw viability |
| US9101590B2 (en) | 2005-07-29 | 2015-08-11 | Yale University | Defined culture conditions of human embryonic stem cells |
| CN101351546B (zh) | 2005-12-21 | 2013-05-29 | 江苏太瑞生诺生物医药科技有限公司 | 治疗播散性癌症的方法 |
| EP1994141B1 (en) | 2006-02-23 | 2017-11-15 | ViaCyte, Inc. | Compositions and methods useful for culturing differentiable cells |
| JP5080779B2 (ja) * | 2006-10-25 | 2012-11-21 | テルモ株式会社 | リポソーム製剤の製造方法 |
| WO2008137641A2 (en) | 2007-05-04 | 2008-11-13 | Whitehead Institute For Biomedical Research | Ex vivo expansion of human hematopoietic stem cells |
| EP2188367A4 (en) | 2007-08-10 | 2010-10-27 | Whitehead Biomedical Inst | HORMON'S TREATIVE TISSUE CULTURE SYSTEM AND USES THEREOF |
| FI20096288A0 (fi) * | 2009-12-04 | 2009-12-04 | Kristiina Rajala | Formulations and methods for culturing stem cells |
| MX2014005723A (es) | 2011-11-11 | 2014-11-25 | Essential Pharmaceuticals Llc | Kit que comprende factores labiles y de reemplazo de suero. |
-
2014
- 2014-12-19 US US14/577,414 patent/US9637721B2/en not_active Expired - Fee Related
- 2014-12-19 AR ARP140104810A patent/AR098875A1/es unknown
- 2014-12-19 AU AU2014364368A patent/AU2014364368A1/en not_active Abandoned
- 2014-12-19 TW TW103144675A patent/TW201527534A/zh unknown
- 2014-12-19 EA EA201691297A patent/EA201691297A1/ru unknown
- 2014-12-19 JP JP2016560860A patent/JP2017500893A/ja active Pending
- 2014-12-19 BR BR112016014488A patent/BR112016014488A2/pt not_active IP Right Cessation
- 2014-12-19 WO PCT/US2014/071388 patent/WO2015095651A1/en not_active Ceased
- 2014-12-19 MX MX2016008251A patent/MX2016008251A/es unknown
- 2014-12-19 EP EP14870754.0A patent/EP3083978A4/en not_active Withdrawn
- 2014-12-19 CN CN201480075947.7A patent/CN106062205A/zh active Pending
- 2014-12-19 KR KR1020167019241A patent/KR20160125352A/ko not_active Withdrawn
- 2014-12-19 SG SG11201604994UA patent/SG11201604994UA/en unknown
- 2014-12-19 CA CA2934487A patent/CA2934487A1/en not_active Abandoned
-
2016
- 2016-06-16 CL CL2016001553A patent/CL2016001553A1/es unknown
- 2016-06-16 IL IL246262A patent/IL246262A0/en unknown
-
2017
- 2017-03-28 US US15/471,621 patent/US20170198251A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| KR20160125352A (ko) | 2016-10-31 |
| CN106062205A (zh) | 2016-10-26 |
| EP3083978A4 (en) | 2017-08-30 |
| AU2014364368A1 (en) | 2016-07-07 |
| MX2016008251A (es) | 2016-10-13 |
| EP3083978A1 (en) | 2016-10-26 |
| WO2015095651A1 (en) | 2015-06-25 |
| BR112016014488A2 (pt) | 2017-08-08 |
| US20150175956A1 (en) | 2015-06-25 |
| TW201527534A (zh) | 2015-07-16 |
| CA2934487A1 (en) | 2015-06-25 |
| US9637721B2 (en) | 2017-05-02 |
| JP2017500893A (ja) | 2017-01-12 |
| SG11201604994UA (en) | 2016-07-28 |
| EA201691297A1 (ru) | 2016-11-30 |
| US20170198251A1 (en) | 2017-07-13 |
| IL246262A0 (en) | 2016-07-31 |
| AR098875A1 (es) | 2016-06-22 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2016001553A1 (es) | Medios para cultivo celular | |
| AR119552A2 (es) | Producción de una n-acetilgalactosamina-6-sulfatasa humana activa altamente fosforilada y sus usos | |
| MX2012009180A (es) | Variantes y composiciones que comprenden variantes con alta estabilidad en presencia de un agente quelante. | |
| MX2018007932A (es) | Composiciones de inoculante estables y metodos para producir las mismas. | |
| BR112015001620A2 (pt) | composição de meio de cultura, e método para cultivo de célula ou tecido usando-se dita composição | |
| CL2013000238A1 (es) | Uso de inhibores de la succinato deshidrogenasa y/o inhibidores del complejo iii para mejorar la relacion entre microorganismos dañinos y beneficiosos. | |
| CO6630182A2 (es) | Microorganismos y métodos para la biosíntesis de butadieno | |
| CL2012002013A1 (es) | Microorganismos aislado thrastochytrium sp. atcc pta-10212 util en la produccion de acidos grasos omega-3 | |
| CO6721031A2 (es) | Composición para mejorar la recuperación de petroleo que incluye microbiosy componentes bassados en el aminoácido n-lauroilo | |
| MX2016015462A (es) | Composicion y metodo para estabilizar y mantener la viabilidad de los microorganismos resistentes. | |
| MX2019000547A (es) | Formulaciones de adamts13 liquidas y liofilizadas, estabilizadas. | |
| IN2014DN07483A (enExample) | ||
| CL2014003225A1 (es) | Composición que comprende un agente de control biológico y un fungicida. | |
| AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
| CO2017004735A2 (es) | Moléculas que tienen utilidad plaguicida e intermediarios, composiciones y procedimientos relacionados con las mismas | |
| CR20150310A (es) | Solución para preservar conductos vasculares | |
| AR082943A1 (es) | Formula nutricional predigerida | |
| AR087911A1 (es) | Metodos en multiples etapas y composiciones para desensibilizar las caras de formaciones subterraneas | |
| CL2012003488A1 (es) | Formulación intravenosa que comprende una solución acuosa de sulfobutil-eter-beta-ciclodextrina y amiodarona o una sal en proporción entre 2,7: 1 a 7:1; metodo de preparación; un artículo manufacturado, util en arritmias. | |
| ECSP17068868A (es) | Archaebacteria en alimento para animales bioactivo, método para hacer la composición y métodos que emplean la composición | |
| CO7240370A2 (es) | Forma farmaceútica para la liberación prolongada de sustancias activas | |
| CL2012002781A1 (es) | Producto que comprende un cuerpo de alimento compuesto por un componente de alimento y un componente de infusion que contiene mal todextrina en una concentracon de 5 a 65% con respecto al cuerpo del alimento; producto alimenticio; metodo para producir un cuerpo de alimento infusionado; y formulaciones de infusion. | |
| BR112014011198A2 (pt) | dispositivos e métodos para aumento da viabiliade de bactérias em forma de bastonete | |
| MX375276B (es) | Biomarcadores para canceres que responden a moduladores de la actividad de hec1. | |
| MX375183B (es) | Formulaciones de acamprosato, metodos de uso de las mismas, y combinaciones que comprenden las mismas. |